Theoretical study of 3-D molecular similarity and ligand binding modes of orthologous human and rat D2 dopamine receptors. - Marvin A. Soriano-Ursúa; Jorge O. Ocampo-López; Karina Ocampo-Mendoza; José G. Trujillo-Ferrara; José Correa-Basurto (Comput. Biol. Medicine, 2011)

A computational analysis of the binding mode of closantel as inhibitor of the Onchocerca volvulus chitinase: insights on macrofilaricidal drug design. - Aldo Segura-Cabrera; Virgilio Bocanegra-García; Cristian Lizarazo-Ortega; Xianwu Guo; José Correa-Basurto; Mario A. Rodríguez-Pérez (J. Comput. Aided Mol. Des., 2011)

Seeking potential anticonvulsant agents that target GABAA receptors using experimental and theoretical procedures. - Margarita Virginia Saavedra-Vélez; José Correa-Basurto; Myrna H. Matus; Eloy Gasca-Pérez; Martiniano Bello; Roberto Cuevas-Hernández; Rosa Virginia García-Rodríguez; José G. Trujillo-Ferrara; Fernando Rafael Ramos-Morales (J. Comput. Aided Mol. Des., 2014)

Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach. - Yudibeth Sixto-López; Martiniano Bello; José Correa-Basurto (J. Comput. Aided Mol. Des., 2020)

Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations. - Luz América Chi; Somayeh Asgharpour; José Correa-Basurto; Cindy Rodríguez Bandala; Marlet Martínez-Archundia (J. Comput. Aided Mol. Des., 2022)

In silico study suggests potential drugs that target CD151 to treat breast cancer and glioblastoma. - Gema Ramírez-Salinas; Martha Cecilia Rosales-Hernandéz; José Correa-Basurto; Issac Guerrero-González; Selene Saraí Hernández-Castro; Marlet Martínez-Archundia (J. Comput. Chem., 2024)